Centrum Pharmaceuticals: The new crown oral drug Centrum will go into production immediately and will be priced significantly lower than Pfizer Paxlovid
Read Time:30 Second
The reporter learned from Centrin Pharmaceuticals that Centrin will be put into production immediately after being approved for marketing, and will be distributed to the most needed regions and medical institutions as a priority during the initial production capacity climbing stage, and will actively expand its production capacity subsequently. After Cianoxin enters circulation, it will serve the needs of patients through hospitals, online Internet hospitals and other channels. Note: The State Drug Administration (SDA) today announced conditional approval for the launch of Centrin, a Class 1 innovative drug for the treatment of adult patients with mild to moderate neoconjunctivitis.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating